share_log

金斯瑞生物科技：传奇生物预期上半年净亏损为7540万美元至8740万美元

Genscript Bio: Legend Biotech expects a net loss of $75.4 million to $87.4 million in the first half of the year.

Zhitong Finance ·  Jul 26 19:36

Genscript Bio (01548) announced that Legend Biotech is expected to achieve adjusted net losses in the first half of 2024...

According to the Zhitoon Finance App, Genscript Bio (01548) has announced that in the first half of 2024, Legend Biotech is expected to have an adjusted net loss of approximately $94.7 million to $0.1097 billion, and a net loss of expected to be between $75.4 million and $87.4 million.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment